Pall Corp. has signed a commercial collaboration with RoosterBio Inc., for the co-development and marketing of complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs). These systems aim to enable the biopharma industry to accelerate product development, reduce clinical translation timelines and help streamline the commercialization pathway for stem cell-based therapies.   Stem cell-based technologies are progressing rapidly through the clini...